Visit https://www.peervoice.com/XUZ860 to view the entire programme with slides. After completing “Can We Afford Not To? Optimizing Use of G-CSF Biosimilars in Supportive Cancer Care in Canada”, participants will be able to: Outline the key barriers to optimal prophylactic use of G-CSF biosimilars in supportive cancer care in Canada; Discuss the potential benefits of biosimilar G-CSF use, from the patient care and health economics perspectives.